Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents
- PMID: 33539685
- PMCID: PMC7880703
- DOI: 10.1002/cpz1.36
Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents
Erratum in
-
Group Correction Statement (Data Availability Statements).Curr Protoc. 2022 Aug;2(8):e552. doi: 10.1002/cpz1.552. Curr Protoc. 2022. PMID: 36005902 Free PMC article. No abstract available.
Abstract
Class II major histocompatibility complex peptide (MHC-IIp) multimers are precisely engineered reagents used to detect T cells specific for antigens from pathogens, tumors, and self-proteins. While the related Class I MHC/peptide (MHC-Ip) multimers are usually produced from subunits expressed in E. coli, most Class II MHC alleles cannot be produced in bacteria, and this has contributed to the perception that MHC-IIp reagents are harder to produce. Herein, we present a robust constitutive expression system for soluble biotinylated MHC-IIp proteins that uses stable lentiviral vector-transduced derivatives of HEK-293T cells. The expression design includes allele-specific peptide ligands tethered to the amino-terminus of the MHC-II β chain via a protease-cleavable linker. Following cleavage of the linker, HLA-DM is used to catalyze efficient peptide exchange, enabling high-throughput production of many distinct MHC-IIp complexes from a single production cell line. Peptide exchange is monitored using either of two label-free methods, native isoelectric focusing gel electrophoresis or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry of eluted peptides. Together, these methods produce MHC-IIp complexes that are highly homogeneous and that form the basis for excellent MHC-IIp multimer reagents. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Lentivirus production and expression line creation Support Protocol 1: Six-well assay for estimation of production cell line yield Support Protocol 2: Universal ELISA for quantifying proteins with fused leucine zippers and His-tags Basic Protocol 2: Cultures for production of Class II MHC proteins Basic Protocol 3: Purification of Class II MHC proteins by anti-leucine zipper affinity chromatography Alternate Protocol 1: IMAC purification of His-tagged Class II MHC Support Protocol 3: Protein concentration measurements and adjustments Support Protocol 4: Polishing purification by anion-exchange chromatography Support Protocol 5: Estimating biotinylation percentage by streptavidin precipitation Basic Protocol 4: Peptide exchange Basic Protocol 5: Analysis of peptide exchange by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry Alternate Protocol 2: Native isoelectric focusing to validate MHC-II peptide loading Basic Protocol 6: Multimerization Basic Protocol 7: Staining cells with Class II MHC tetramers.
Keywords: Class II MHC multimers; Class II MHC tetramers; antigen-specific T cells; flow cytometry; lentiviral transduction; protein engineering; protein expression; protein purification.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICTS OF INTEREST
None of the authors have any conflicts of interest to declare.
Figures
References
-
- Altman JD 2004. Flow Cytometry Applications of MHC Tetramers. Methods in Cell Biology 75:433–452. - PubMed
-
-
Altman JD, and Davis MM 2016. MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells. Current Protocols in Immunology 115:17.3.1–17.3.44.
A Current Protocols unit that updates the original 2003 unit and that describes the production of class I MHC tetramers
-
-
-
Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, and Davis MM 1996. Phenotypic Analysis of Antigen-Specific T Lymphocytes. Science 274:94–96.
The first paper to describe the MHC tetramer method
-
-
- Bankovich AJ, Girvin AT, Moesta AK, and Garcia KC 2004. Peptide register shifting within the MHC groove: theory becomes reality. Molecular Immunology 40:1033–1039. - PubMed
MeSH terms
Substances
Grants and funding
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- 75N93022D00005/AI/NIAID NIH HHS/United States
- P51 OD011132/OD/NIH HHS/United States
- HHSN272201300006C/AI/NIAID NIH HHS/United States
- 75N93020D00005/GF/NIH HHS/United States
- 75N93023D00005/AI/NIAID NIH HHS/United States
- N01 AI025456/AI/NIAID NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- 75N99020D00005/OF/ORFDO NIH HHS/United States
- 272201300006C/GF/NIH HHS/United States
- U19 AI111211/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- 75N95020D00005/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
